Physician profile
Paul K Gerth
NPI 1417908799
$6,787.02
in general payments reported to CMS, 2019-2025
22 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,208 · 2020: $15.24 · 2021: $2,307 · 2022: $1,429 · 2023: $134 · 2024: $1,427 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,146 · Food and Beverage: $655 · Entertainment: $26.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,146.31 |
| Food and Beverage | $654.98 |
| Entertainment | $26.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,973.35 | 2021-2024 | |
| Stryker Corporation | $1,857.96 | 2019-2025 | Blueprint Patient Specific Instrumentation, Asnis, Salvation |
| Alpha Orthopedic Systems | $1,552.83 | 2019-2021 | |
| Crossroads Orthopedics, LLC | $942.92 | 2022-2024 | |
| Depuy Synthes Sales INC. | $130.94 | 2019-2025 | Monovisc, Orthovisc, Peak |
| Abbott Laboratories | $36.71 | 2023-2025 | Eterna, Proclaim |
| Bioventus LLC | $35.68 | 2023-2025 | Supartz Fx Sodium Hyaluronate, Supartz Fx Sodium Hyaluronate |
| Melinta Therapeutics, LLC | $32.81 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.24 | 2024 | Iovera, Zilretta, Exparel |
| Horizon Therapeutics Plc | $21.21 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.85 | 2019 | |
| Amgen INC. | $19.07 | 2023 | Evenity |
| Ferring Pharmaceuticals INC. | $17.31 | 2019 | |
| Wright Medical Technology, INC. | $15.89 | 2019 | |
| Avanos Medical | $15.57 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $15.24 | 2020 | |
| Vericel Corporation | $14.55 | 2023 | Maci |
| Vertex Pharmaceuticals Incorporated | $13.94 | 2025 | |
| Kci USA, INC. | $12.18 | 2019 | |
| Smith+Nephew, INC. | $11.93 | 2019 | |
| Medartis INC. | $11.67 | 2021 | |
| Sonex Health, INC. | $10.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Gerth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.